Skip to main content
Top
Published in: World Journal of Surgery 5/2006

01-05-2006

Classical and Follicular Variant of Papillary Thyroid Carcinoma: A Comparative Study on Clinicopathologic Features and Long-term Outcome

Authors: Brian Hung-Hin Lang, MBBS (syd.), Chung-Yau Lo, MBBS (HK), MS (HK), Wai-Fan Chan, MBBS (HK), Alfred King-Yin Lam, MD (HK), Koon-Yat Wan, MBBS (HK)

Published in: World Journal of Surgery | Issue 5/2006

Login to get access

Abstract

Introduction

The follicular variant of papillary thyroid carcinoma (FVPTC) is the most common histologic subtype of papillary thyroid carcinoma (PTC). However, it is still controversial whether FVPTC should behave differently from classical PTC (CPTC). The present study aimed at evaluating any potential difference in clinicopathologic features and long-term outcome of FVPTC as compared with CPTC.

Patients and Methods

Of 568 patients with PTC managed from 1973 to 2004, 308 were shown to have CPTC (54.2%) and 67 (11.8%) FVPTC after histologic review. The mean (± SD) follow-up period was 11.3 (± 8.9) years. The two groups were compared in terms of clinicopathological features, treatment received, and outcome regarding recurrence and disease-specific survival.

Results

There was no difference in age and gender ratio between the CPTC and FVPTC patients. Both groups had similar tumor characteristics in terms of tumor size, presence of multifocality, capsular invasion, lymphovascular permeation, and perineural infiltration. However, FVPTC patients had significantly fewer histologically confirmed cervical lymph node metastases (P = 0.027) and extrathyroidal involvement (P = 0.005). The proportion of bilateral resection, adjuvant radioactive iodine, and lymph node dissection did not differ significantly between the two groups. The FVPTC patients had a more favorable tumor risk by DeGroot classification (P = 0.003) and MACIS (Metastasis, Age, Completeness of excision, Invasiveness, and Size) score (P = 0.026). The 10- and 15-year actuarial disease-specific survivals did not differ significantly between FVPTC and CPTC patients (96.2% versus 90.7% and 96.2% versus 89.1%, respectively).

Conclusions

Although patients with FVPTC had more favorable clinicopathologic features and a better tumor risk group profile, their long-term outcome was similar to that of CPTC patients.
Literature
1.
go back to reference Tielens ET, Sherman SI, Hruban RH, et al. Follicular variant of papillary thyroid carcinoma: a clinicopathologic study. Cancer 1994;73:424–431PubMed Tielens ET, Sherman SI, Hruban RH, et al. Follicular variant of papillary thyroid carcinoma: a clinicopathologic study. Cancer 1994;73:424–431PubMed
2.
go back to reference Ortiz Sebastian S, Rodriguez Gonazles JM, Parilla Paricio P, et al. Papillary thyroid carcinoma: prognostic index for survival including the histological variety. Arch Surg 2000;135:272–277CrossRef Ortiz Sebastian S, Rodriguez Gonazles JM, Parilla Paricio P, et al. Papillary thyroid carcinoma: prognostic index for survival including the histological variety. Arch Surg 2000;135:272–277CrossRef
3.
go back to reference Zidan J, Karen D, Stein M, et al. Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival. Cancer 2003;97:1181–1185CrossRefPubMed Zidan J, Karen D, Stein M, et al. Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival. Cancer 2003;97:1181–1185CrossRefPubMed
4.
go back to reference Crile GJ, Hazard JB. Relationship of the age of the patient to the natural history and prognosis of carcinoma of the thyroid. Ann Surg 1953:138:33–38PubMed Crile GJ, Hazard JB. Relationship of the age of the patient to the natural history and prognosis of carcinoma of the thyroid. Ann Surg 1953:138:33–38PubMed
5.
go back to reference Passler C, Prager G, Scheuba C, et al. Follicular variant of papillary thyroid carcinoma: a long-term follow-up. Arch Surg 2003;138:1362–1366CrossRefPubMed Passler C, Prager G, Scheuba C, et al. Follicular variant of papillary thyroid carcinoma: a long-term follow-up. Arch Surg 2003;138:1362–1366CrossRefPubMed
6.
go back to reference Burningham AR, Krishnan J, Davidson BJ, et al. Papillary and follicular variant of papillary carcinoma of the thyroid: initial presentation and response to therapy. Otolaryngol Head Neck Surg 2005;132:840–844CrossRefPubMed Burningham AR, Krishnan J, Davidson BJ, et al. Papillary and follicular variant of papillary carcinoma of the thyroid: initial presentation and response to therapy. Otolaryngol Head Neck Surg 2005;132:840–844CrossRefPubMed
7.
go back to reference Carcangiu ML, Zampi G, Pupi A, et al. Papillary carcinoma of the thyroid: a clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 1985;55:805–828PubMed Carcangiu ML, Zampi G, Pupi A, et al. Papillary carcinoma of the thyroid: a clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 1985;55:805–828PubMed
8.
go back to reference Falvo L, Catanio A, D’Andrea V, et al. Prognostic importance of histologic vascular invasion in papillary thyroid carcinoma. Ann Surg 2005;241:640–646CrossRefPubMed Falvo L, Catanio A, D’Andrea V, et al. Prognostic importance of histologic vascular invasion in papillary thyroid carcinoma. Ann Surg 2005;241:640–646CrossRefPubMed
9.
go back to reference Lloyd RV, DeLellis RA, Heitz PU, et al. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Endocrine Organs, IARC (International Agency for Research on Cancer) Press, Lyons, France, 2004 Lloyd RV, DeLellis RA, Heitz PU, et al. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Endocrine Organs, IARC (International Agency for Research on Cancer) Press, Lyons, France, 2004
10.
go back to reference Lloyd RV, Erickson LA, Casey MB, et al. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol 2004;28:1336–1340PubMed Lloyd RV, Erickson LA, Casey MB, et al. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol 2004;28:1336–1340PubMed
11.
go back to reference Lo CY, Chan WF, Lam KY, et al. Optimizing the treatment of AMES high-risk papillary thyroid carcinoma. World J Surg 2004;28:1103–1109CrossRefPubMed Lo CY, Chan WF, Lam KY, et al. Optimizing the treatment of AMES high-risk papillary thyroid carcinoma. World J Surg 2004;28:1103–1109CrossRefPubMed
12.
go back to reference Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988;104:947–953PubMed Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988;104:947–953PubMed
13.
go back to reference UICC (International Union Against Cancer). TNM Classification of Malignant Tumor, 5th ed. (Editors: Sobin LH, Wittlekind C), New York, Wiley-Liss, 1997 UICC (International Union Against Cancer). TNM Classification of Malignant Tumor, 5th ed. (Editors: Sobin LH, Wittlekind C), New York, Wiley-Liss, 1997
14.
go back to reference DeGroot LJ, Kaplan EL, McCormick M, et al. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metabol 1990;71:414–424CrossRef DeGroot LJ, Kaplan EL, McCormick M, et al. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metabol 1990;71:414–424CrossRef
15.
go back to reference Hay ID, Bergstrath EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 to 1989. Surgery 1993;114:1056–1058 Hay ID, Bergstrath EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 to 1989. Surgery 1993;114:1056–1058
16.
go back to reference LiVolsi VA. Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival. Cancer 2003;98:1997; author reply 1997–1998CrossRefPubMed LiVolsi VA. Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival. Cancer 2003;98:1997; author reply 1997–1998CrossRefPubMed
17.
go back to reference Baloch ZW, LiVolsi VA. Follicular-patterned lesions of the thyroid: the bane of the pathologist. Am J Clin Pathol 2002;117:143–150CrossRefPubMed Baloch ZW, LiVolsi VA. Follicular-patterned lesions of the thyroid: the bane of the pathologist. Am J Clin Pathol 2002;117:143–150CrossRefPubMed
18.
go back to reference Zhu Z, Gandhi M, Nikiforova MN, et al. Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma: an unusually high prevalence of ras mutations. Am J Clin Pathol 2003;120:71–77CrossRefPubMed Zhu Z, Gandhi M, Nikiforova MN, et al. Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma: an unusually high prevalence of ras mutations. Am J Clin Pathol 2003;120:71–77CrossRefPubMed
19.
go back to reference Trovisco V, de Castro IV, Soares P, et al. BRAF mutations are associated with some histiotypes of papillary thyroid carcinoma. J Pathol 2004;202:247–251CrossRefPubMed Trovisco V, de Castro IV, Soares P, et al. BRAF mutations are associated with some histiotypes of papillary thyroid carcinoma. J Pathol 2004;202:247–251CrossRefPubMed
20.
go back to reference Lo CY, Lam KY, Leung PP, et al. High prevalence of cyclooxygenase 2 expression in papillary thyroid carcinoma. Eur J Endocrinol 2005:152:545–550CrossRefPubMed Lo CY, Lam KY, Leung PP, et al. High prevalence of cyclooxygenase 2 expression in papillary thyroid carcinoma. Eur J Endocrinol 2005:152:545–550CrossRefPubMed
Metadata
Title
Classical and Follicular Variant of Papillary Thyroid Carcinoma: A Comparative Study on Clinicopathologic Features and Long-term Outcome
Authors
Brian Hung-Hin Lang, MBBS (syd.)
Chung-Yau Lo, MBBS (HK), MS (HK)
Wai-Fan Chan, MBBS (HK)
Alfred King-Yin Lam, MD (HK)
Koon-Yat Wan, MBBS (HK)
Publication date
01-05-2006
Publisher
Springer-Verlag
Published in
World Journal of Surgery / Issue 5/2006
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-005-0356-7

Other articles of this Issue 5/2006

World Journal of Surgery 5/2006 Go to the issue